Omega-3 fatty acids have been associated with lowering TG; however, robust data for clinical outcomes have been lacking until the recent publication of the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT).2,3 This blog will give a brief review of historical evidence, detail differences in fish oil supplements, and provide considerations for the role of Vascepa (icosapent ethyl) in high-risk patients with dyslipidemia.
Career Reflections: Learning to Say “No”
Becoming a new practitioner will be one of the most exciting times in your career, but having a lot of autonomy might also seem a bit unnerving at first. In this post, we’ll cover one of the most important skills to learn during this transition: saying “no.”